13F filer · CIK 902219 ↗
Wellington Management Group LLP
You are looking at Q3 2019. See the latest, Q2 2026 →
Reported value
$443.46B
−1.8% on the quarter before
Positions
2,013
181 new · 207 sold out
Top 10
15.3%
of the value
Est. gain
+$2.06B
on stocks held all quarter
Est. return
+0.5%
on those stocks since Q2 2019
Positions as of Sep 30, 2019, from Wellington Management Group LLP's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 29% of the reported value, each sized by its share, colored by what the fund did with it since Q2 2019. Striped tiles are options.
Largest buys
Since Q2 2019, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Pfizer Inc~$1.44BAdded · 1.3% → 1.4%+40,033,763 shares
- L3harris Technologies Inc~$1.07BNew · 0.0% → 0.2%+5,151,029 shares
- Eli Lilly~$877.5MAdded · 0.8% → 1.0%+7,846,902 shares
- Blackstone Group Inc~$748.5MNew · 0.0% → 0.2%+15,324,614 shares
- United Technologies Corp~$596.2MAdded · 0.5% → 0.7%+4,367,047 shares
- American Express Co~$553.4MAdded · 0.6% → 0.7%+4,678,893 shares
- Corning Inc.~$485.3MAdded · 0.0% → 0.1%+17,014,846 shares
- Archer Daniels Midland Co~$464.4MAdded · 0.1% → 0.2%+11,306,874 shares
- Cvs Health Corp~$425.6MAdded · 0.4% → 0.6%+6,747,788 shares
- Progressive Corp Ohio~$380.5MAdded · 0.2% → 0.3%+4,925,099 shares
Largest sells
Since Q2 2019, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Allergan Plc~$3.55BCut · 0.8% → 0.1%−21,083,760 shares
- American Tower~$1.27BCut · 1.1% → 0.9%−5,740,467 shares
- Harris Corp Del~$1.23BSold out · 0.3% → 0.0%−6,514,827 shares
- Amazon~$735.1MCut · 1.2% → 0.9%−423,441 shares
- Total Sys Svcs Inc~$713.8MSold out · 0.2% → 0.0%−5,565,072 shares
- Nextera Energy Inc~$621.4MCut · 0.6% → 0.5%−2,667,205 shares
- Apple~$618.4MCut · 0.7% → 0.7%−2,761,221 shares
- Ihs Markit Ltd~$568.1MCut · 0.4% → 0.2%−8,494,275 shares
- United Parcel Service Inc~$523.4MCut · 0.4% → 0.3%−4,368,143 shares
- Microsoft~$518.0MCut · 2.3% → 2.3%−3,726,011 shares
Holdings
As of Sep 30, 2019. Changes are in shares against Jun 30, 2019, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOM · shares −4.9% · price +3.8% | 2.3% | $10.14B | +$369.8M | ||||||||
| Medtronic PlcSHS · shares +3.6% · price +11.5% | 1.8% | $7.94B | +$792.5M | ||||||||
| Verizon Communications IncCOM · shares −3.9% · price +5.7% | 1.6% | $6.95B | +$371.8M | ||||||||
| Bank Amer CorpCOM · shares −0.3% · price +0.6% | 1.5% | $6.84B | +$39.9M | ||||||||
| Jpmorgan Chase & CoCOM · shares +0.8% · price +5.3% | 1.5% | $6.81B | +$338.2M | ||||||||
| Unitedhealth Group IncCOM · shares −1.9% · price −10.9% | 1.5% | $6.60B | −$810.6M | ||||||||
| Pfizer IncCOM · shares +30% · price −17.1% | 1.4% | $6.28B | −$995.5M | ||||||||
| Comcast Corp NewCL A · shares +1.4% · price +6.6% | 1.3% | $5.64B | +$345.5M | ||||||||
| Bristol Myers Squibb CoCOM · shares −3.5% · price +11.8% | 1.3% | $5.56B | +$587.8M | ||||||||
| AlphabetCAP STK CL A · shares +6.2% · price +12.8% | 1.2% | $5.11B | +$545.2M | ||||||||
| Coca Cola CoCOM · shares +0.5% · price +6.9% | 1.1% | $5.06B | +$325.6M | ||||||||
| Chubb LimitedCOM · shares +2.5% · price +9.6% | 1.1% | $4.93B | +$421.8M | ||||||||
| Merck & Co IncCOM · shares +4.7% · price +0.4% | 1.1% | $4.86B | +$18.2M | ||||||||
| Home Depot IncCOM · shares +2.9% · price +11.6% | 1.1% | $4.69B | +$472.5M | ||||||||
| Lockheed Martin CorpCOM · shares −7.5% · price +7.3% | 1.0% | $4.56B | +$309.8M | ||||||||
| Chevron Corp NewCOM · shares −7.5% · price −4.7% | 1.0% | $4.47B | −$220.2M | ||||||||
| Eli LillyCOM · shares +25% · price +0.9% | 1.0% | $4.44B | +$33.1M | ||||||||
| AmazonCOM · shares −15% · price −8.3% | 0.93% | $4.12B | −$374.0M | ||||||||
| American TowerCOM · shares −24% · price +8.2% | 0.91% | $4.05B | +$305.2M | ||||||||
| Exxon Mobil CorpCOM · shares +1.5% · price −7.9% | 0.86% | $3.80B | −$319.0M | ||||||||
| Tjx Cos Inc NewCOM · shares +5.6% · price +5.4% | 0.82% | $3.64B | +$177.1M | ||||||||
| IntelCOM · shares −6.3% · price +7.6% | 0.80% | $3.54B | +$251.6M | ||||||||
| Pnc Finl Svcs Group IncCOM · shares −10% · price +2.1% | 0.77% | $3.41B | +$70.1M | ||||||||
| Union Pacific CorpCOM · shares +9.9% · price −4.2% | 0.77% | $3.41B | −$136.5M | ||||||||
| Abbott LabsCOM · shares −8.1% · price −0.5% | 0.77% | $3.40B | −$17.5M | ||||||||
| Total · 2,013 positions | 100% | $443.46B | +$2.06B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q2 2019 to Q3 2019: 1,761 stocks held throughout, up $2.06B (+0.5%).
- Medtronic Plc+$792.5M+12%
- Bristol Myers Squibb Co+$587.8M+12%
- Alphabet+$545.2M+13%
- Home Depot Inc+$472.5M+12%
- Chubb Limited+$421.8M+10%
- Anthem Inc−$338.8M−15%
- Cisco−$350.6M−10%
- Amazon−$374.0M−8%
- Unitedhealth Group Inc−$810.6M−11%
- Pfizer Inc−$995.5M−17%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 3 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $580.17B+8% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $535.46B−6% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $570.66B−0% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $571.31B+4% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $550.98B+6% | SEC ↗ |
| Q1 2025 | May 13, 2025 | $519.87B−5% | SEC ↗ |
| Q4 2024 | Feb 12, 2025 (amended) | $546.18B−4% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $570.97B+2% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $560.18B−1% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $564.44B+5% | SEC ↗ |
| Q4 2023 | Feb 12, 2024 (amended) | $536.37B+7% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 (amended) | $499.52B−5% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $527.49B+5% | SEC ↗ |
| Q1 2023 | May 12, 2023 | $504.61B+1% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $498.70B+6% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $469.49B−5% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $496.55B−15% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $583.99B−7% | SEC ↗ |
| Q4 2021 | Feb 11, 2022 | $625.28B+6% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $587.95B−2% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $600.78B+6% | SEC ↗ |
| Q1 2021 | May 17, 2021 | $567.83B+5% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $543.08B+12% | SEC ↗ |
| Q3 2020 | Nov 16, 2020 | $483.12B+8% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $449.13B+19% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $377.87B−21% | SEC ↗ |
| Q4 2019 | Feb 11, 2020 | $477.16B+8% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $443.46B−2% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $451.69B+2% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $441.54B+11% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $399.54B−16% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $474.88B+6% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $449.23B+2% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $441.92B−2% | SEC ↗ |
| Q4 2017 | Feb 13, 2018 | $452.59B+4% | SEC ↗ |
| Q3 2017 | Nov 13, 2017 | $435.63B+3% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $424.69B+2% | SEC ↗ |
| Q1 2017 | May 11, 2017 | $415.20B+4% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $398.65B−0% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $399.22B+3% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $386.87B+2% | SEC ↗ |
| Q1 2016 | May 13, 2016 | $379.99B | SEC ↗ |